Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous labetalol versus nicardipine for severe hypertension in severe preeclampsia
ISRCTN76310309Phase 4Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in preeclampsia comparing Intravenous labetalol with Intravenous nicardipine (2 arms). Primary endpoint: Time to target blood pressure. Started Sep 2025; status: completed.
02
Drugs
labetalolnicardipine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ISRCTN76310309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN76310309.